PIM447 (LGH447) Hydrochloride

製品コード：S7985 純度：99.06%

PIM447 (LGH447) Hydrochloride is a novel pan-PIM kinase inhibitor with Ki values of 6 pM, 18 pM, 9 pM for PIM1, PIM2, PIM3 respectively. It also inhibits GSK3β, PKN1, and PKCτ, but at a significantly lower potency with IC50 between 1 and 5 μM (>10⁵-fold differential relative to the Ki on PIMs). PIM447 induces apoptosis.

CAS No. 1210416-52-6

サイズ	価格(税別)	在庫状況
10mM (1mL in DMSO)	JPY 67000	国内在庫あり
2mg	JPY 29500	国内在庫あり
5mg	JPY 55500	国内在庫あり

代表番号: 045-509-1970\|電子メール：[email protected] よく尋ねられる質問

文献中Selleckの製品使用例（20）

カスタマーフィードバック1例

製品安全説明書

現在のバッチを見る：純度： 99.06%

99.06

PIM447 (LGH447) Hydrochloride関連製品

関連ターゲット	Pim1 Pim2 Pim3	もっと見る
関連製品	SGI-1776 free base AZD1208 SMI-4a CX-6258 HCl Uzansertib (INCB053914) TP-3654 Hispidulin SMI-16a	もっと見る
関連化合物ライブラリー	Kinase Inhibitor Library FDA-approved Drug Library Natural Product Library Tyrosine Kinase Inhibitor Library JAK/STAT compound library	もっと見る

シグナル伝達経路

Pimシグナル伝達経路

Pim阻害剤の選択性比較

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	活性情報	PMID
KG1	Function assay	100 mg/kg	24 hrs	Unbound plasma concentration in mouse xenografted with human KG1 cells at 100 mg/kg, po after 24 hrs by LC/MS/MS analysis, Cp(f)=0.3μM	26505898
KG1	Antitumor assay	30 mg/kg	11 days	Antitumor activity against human KG1 cells xenografted in mouse assessed as tumor stasis at 30 mg/kg, po qd measured after 11 days post tumor implantation	26505898
KG1	Antitumor assay	30 to 100 mg/kg	11 days	Antitumor activity against human KG1 cells xenografted in mouse assessed as tumor regression at 30 to 100 mg/kg, po qd measured after 11 days post tumor implantation in presence of 100 mg/kg Ara-C	26505898
MOLM16	Antiproliferative assay		3 days	Antiproliferative activity against human MOLM16 cells after 3 days by CellTiter-Glo assay, GI50=0.01μM	26505898
KG1	Antiproliferative assay		3 days	Antiproliferative activity against human KG1 cells after 3 days by CellTiter-Glo assay, GI50=0.01μM	26505898
EOL-1	Antiproliferative assay		3 days	Antiproliferative activity against human EOL-1 cells after 3 days by CellTiter-Glo assay, GI50=0.01μM	26505898
M07e	Antiproliferative assay		3 days	Antiproliferative activity against human M07e cells after 3 days by CellTiter-Glo assay, GI50=0.05μM	26505898
UKE1	Antiproliferative assay		3 days	Antiproliferative activity against human UKE1 cells after 3 days by CellTiter-Glo assay, GI50=0.09μM	26505898
MV411	Antiproliferative assay		3 days	Antiproliferative activity against human MV411 cells after 3 days by CellTiter-Glo assay, GI50=0.13μM	26505898
KMS11	Antiproliferative assay		72 hrs	Antiproliferative activity against luciferase expressing human KMS11 cells after 72 hrs by Cell-TiterGlo assay, EC50=0.17μM	26505898
KMS11	Function assay		1 hr	Inhibition of PIM kinase in luciferase expressing human KMS11 cells assessed as inhibition of phosphorylation of S6RP after 1 hr by electrochemiluminescence assay, EC50=0.18μM	26505898
CMK	Antiproliferative assay		3 days	Antiproliferative activity against human CMK cells after 3 days by CellTiter-Glo assay, GI50=0.28μM	26505898
SET2	Antiproliferative assay		3 days	Antiproliferative activity against human SET2 cells after 3 days by CellTiter-Glo assay, GI50=0.48μM	26505898
CMK-11-5	Antiproliferative assay		3 days	Antiproliferative activity against human CMK-11-5 cells after 3 days by CellTiter-Glo assay, GI50=1.03μM	26505898
MOLM13	Antiproliferative assay		3 days	Antiproliferative activity against human MOLM13 cells after 3 days by CellTiter-Glo assay, GI50=1.39μM	26505898
HEL 92.1.7	Antiproliferative assay		3 days	Antiproliferative activity against human HEL 92.1.7 cells after 3 days by CellTiter-Glo assay, GI50=1.66μM	26505898
TF1	Antiproliferative assay		3 days	Antiproliferative activity against human TF1 cells after 3 days by CellTiter-Glo assay, GI50=1.96μM	26505898
MUTZ8	Antiproliferative assay		3 days	Antiproliferative activity against human MUTZ8 cells after 3 days by CellTiter-Glo assay, GI50=1.99μM	26505898
OCI-M1	Antiproliferative assay		3 days	Antiproliferative activity against human OCI-M1 cells after 3 days by CellTiter-Glo assay, GI50=2.57μM	26505898
SKM1	Antiproliferative assay		3 days	Antiproliferative activity against human SKM1 cells after 3 days by CellTiter-Glo assay, GI50=2.69μM	26505898
OCI-AML3	Antiproliferative assay		3 days	Antiproliferative activity against human OCI-AML3 cells after 3 days by CellTiter-Glo assay, GI50=2.92μM	26505898
P31/FUJ	Antiproliferative assay		3 days	Antiproliferative activity against human P31/FUJ cells after 3 days by CellTiter-Glo assay, GI50=5.06μM	26505898
MONO-MAC-1	Antiproliferative assay		3 days	Antiproliferative activity against human MONO-MAC-1 cells after 3 days by CellTiter-Glo assay, GI50=5.19μM	26505898
THP1	Antiproliferative assay		3 days	Antiproliferative activity against human THP1 cells after 3 days by CellTiter-Glo assay, GI50=5.31μM	26505898
OCI-AML2	Antiproliferative assay		3 days	Antiproliferative activity against human OCI-AML2 cells after 3 days by CellTiter-Glo assay, GI50=5.53μM	26505898
NB4	Antiproliferative assay		3 days	Antiproliferative activity against human NB4 cells after 3 days by CellTiter-Glo assay, GI50=7μM	26505898
PL21	Antiproliferative assay		3 days	Antiproliferative activity against human PL21 cells after 3 days by CellTiter-Glo assay, GI50=8.56μM	26505898
SIG-M5	Antiproliferative assay		3 days	Antiproliferative activity against human SIG-M5 cells after 3 days by CellTiter-Glo assay, GI50=8.66μM	26505898
NOMO1	Antiproliferative assay		3 days	Antiproliferative activity against human NOMO1 cells after 3 days by CellTiter-Glo assay, GI50=10μM	26505898
F-36P	Antiproliferative assay		3 days	Antiproliferative activity against human F-36P cells after 3 days by CellTiter-Glo assay, GI50=10μM	26505898
OCI-AML5	Antiproliferative assay		3 days	Antiproliferative activity against human OCI-AML5 cells after 3 days by CellTiter-Glo assay, GI50=10μM	26505898
他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

生物活性

製品説明

Targets

Pim1 ^[1] (Cell-free assay)	Pim3 ^[1] (Cell-free assay)	Pim2 ^[1] (Cell-free assay)
6 pM(Ki)	9 pM(Ki)	18 pM(Ki)

In Vitro
In vitro	The kinase selectivity of PIM447 is first determined in biochemical assays for a panel of 68 diverse protein kinases that included PIM2 as well as 9 lipid kinases. In this panel, only PIM2 is significantly inhibited by PIM447 with an IC50 of <0.003 μM, the lowest sensitivity range for the assay. PIM447 also inhibits GSK3β, PKN1, and PKCτ, but at a significantly lower potency with IC50 between 1 and 5 μM (>105-fold differential relative to the Ki on PIMs). The biochemical IC50 for all other kinases tested in this panel is >9 μM. In follow-up cellular assays of GSK3β inhibition, PIM447 is tested up to 20 μM and is not active^[1]. PIM447 is cytotoxic for myeloma cells due to cell-cycle disruption and induction of apoptosis mediated by a decrease in phospho-Bad (Ser112) and c-Myc levels and the inhibition of mTORC1 pathway. PIM447 also inhibits in vitro osteoclast formation and resorption, downregulates key molecules involved in these processes, and partially disrupts the F-actin ring, while increasing osteoblast activity and mineralization^[2].
細胞実験	細胞株	KG-1 cells
	濃度	0.05, 0.5, and 5 μM
	反応時間	2 h
	実験の流れ	Following treatment of KG-1 cells with PIM447 for 2 h at the indicated concentrations, cells are lysed in RIPA buffer. Protein concentration is determined using a BCA assay, and 50 μg of lysate is separated by SDS-PAGE using 10% bis-Tris gels. Proteins are transferred onto 0.2 μm nitrocellulose membrane, and pS6RP/total S6RP are detected. Following incubation with secondary antibodies, antibody binding is detected using ECL Advance.

In Vivo
In Vivo	Low to moderate in vivo CL is observed for PIM447 across species, as CL values of 20, 28, and 8 mL/min/kg are observed in mouse, rat, and dog, respectively. The volume of distribution is consistently large across species, with Vss of 5.3, 6.4, and 3.6 L/kg observed in mouse, rat, and dog, respectively. Additionally, PIM447 exhibits high oral bioavailability across species, as 84%, 70%, and 71% is observed in mouse, rat, and dog, respectively. The stability of PIM447 in human plasma is high, >90% after a 3 h incubation, and the human plasma protein binding of PIM447 is 95%. With the combination of potent in vitro activity and low to moderate CL, PIM447 demonstrates in vivo target modulation (pS6RP), single agent antitumor activity in a KG-1 AML mouse xenograft model, and druglike properties suitable for development^[1]. PIM447 significantly reduces the tumor burden and prevents tumor-associated bone loss in a disseminated murine model of human myeloma^[2].
動物実験	動物モデル	KG-1 AML xenograft mouse model
	投与量	30 or 100 mg/kg
	投与経路	oral administration

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
臨床試験 (data from https://clinicaltrials.gov, updated on 2024-05-22)
NCT02160951	Completed	Multiple Myeloma	Novartis Pharmaceuticals\|Novartis	September 2014	Phase 1
NCT02078609	Completed	AML and High Risk MDS	Novartis Pharmaceuticals\|Novartis	March 20 2014	Phase 1
NCT01456689	Completed	Multiple Myeloma	Novartis Pharmaceuticals\|Novartis	April 25 2012	Phase 1

参考
[1] Burger MT, et al. J Med Chem. 2015, 58(21):8373-86. [2] Paíno T, et al. Clin Cancer Res. 2017, 23(1):225-238.

参考

化学情報

分子量	476.92	化学式	C₂₄H₂₃F₃N₄O.HCl
CAS No.	1210416-52-6	SDF	--
Smiles	CC1CC(CC(C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F
保管	3年-20°C粉	溶液の保管冷凍と解凍の繰り返しを避けるため小分けにしてください	1年-80°Cin solvent
保管	3年-20°C粉	溶液の保管冷凍と解凍の繰り返しを避けるため小分けにしてください	1个月-20°Cin solvent

In vitro
Batch:

DMSO : 95 mg/mL ( (199.19 mM)；吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Ethanol : 95 mg/mL

Water : Insoluble

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

実験計算

モル濃度計算器

質量	濃度	体積	分子量
=	×	×

希釈計算器分子量計算器

投与溶液組成計算機(クリア溶液)

ステップ１：実験データを入力してください。（実験操作によるロスを考慮し、動物数を1匹分多くして計算・調製することを推奨します）

投与量 mg/kg 動物平均体重 g 投与体積（動物毎）μL 動物数匹

ステップ２：投与溶媒の組成を入力してください。（ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください）

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

計算結果：

投与溶媒濃度： mg/ml;

DMSOストック溶液調製方法： mg 試薬を μL DMSOに溶解する（濃度 mg/mL, 注：濃度が当該ロットのDMSO溶解度を超える場合はご連絡ください。 )

投与溶媒調製方法：Take μL DMSOストック溶液に μL PEG300，を加え、完全溶解後μL Tween 80，を加えて完全溶解させた後 μL ddH₂O，を加え完全に溶解させます。

投与溶媒調製方法：μL DMSOストック溶液に μL Corn oil，を加え、完全溶解。

注意：１.ストック溶液に沈殿、混濁などがないことをご確認ください；
２.順番通りに溶剤を加えてください。次のステップに進む前に溶液に沈殿、混濁などがないことを確認してから加えてください。ボルテックス、ソニケーション、水浴加熱など物理的な方法で溶解を早めることは可能です。

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):